心源性猝死高危病人的识别信栓力邯郸市第一医院心内科邯郸_第1页
心源性猝死高危病人的识别信栓力邯郸市第一医院心内科邯郸_第2页
心源性猝死高危病人的识别信栓力邯郸市第一医院心内科邯郸_第3页
心源性猝死高危病人的识别信栓力邯郸市第一医院心内科邯郸_第4页
心源性猝死高危病人的识别信栓力邯郸市第一医院心内科邯郸_第5页
已阅读5页,还剩53页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、 心源性猝死高危病人的识别信栓力 邯郸市第一医院心内科邯郸市心血管病研究所6个故事揭示猝死的残酷现实:马xx造影后拒绝PCI后8个月猝死,抢救成功李x军PCI术后10天从CCU转至普通病房后1小时猝死宋x亮42岁晚一次胸疼,次日驾车上班途中猝死抢救成功苏x山凌晨4点早八点十点下午3点三次就诊2家医院,均告知没事的情况下在医生面前发生猝死抢救成功 赵x义本院ICD后10月陪人看病时自己猝死;荆x文ICD后4个月早晨被发现猝死于床上。胡xx教师左主干猝死 马某某LAD狭窄猝死 宋xxLCX狭窄猝死后两个抢救成功李xx下午前手术回家邯郸大学老师:救护车都到了,最终放走了上午看病中午就猝死了马xx、绿

2、化路老太太 风险管理的为难处境 医生因此而饱受诟病是医学无能?还是医生无能?是管理问题?还是责任问题?是个体问题?还是社会问题?难道灾难不能预测?不能预防?不能防止吗?发作一次心绞痛就猝死了1疼了许屡次,终于猝死了(1.。)装了ICD还是猝死了(2)不放支架猝死了 vs 放了支架也猝死了上午看病下午就猝死了(2)微结院内患者的SCD预防-Livewest理想的SCD危险分层工具应该:_能够识别出大多数发生VT/VF并且能够除外那些不会发生的患者。筛选出的异常患者接受干预 (medical, surgical, ICD) 能够比一般人群大幅度改善生存状况。Circulation on line

3、8/25/2021现有的SCD主要危险分层工具具有局限性:大多数此类危险分层工具同时对SCD和非SCD提供预后信息,不能区别开来。Circulation on line 8/25/2021由此我们要思考:我们是要预测死亡呢?我们还是要预测死亡方式?猝死不过是一种死亡方式!狭义的猝死应该只指恶性心律失常死亡!而不包括肺栓塞、主动脉瓣狭窄等等Relationshipbetween cardiac mortalityand LVEFN Engl J Med 1983;309:331Value of LVEF for risk stratification after MI: The Multicen

4、ter Postinfarction Research GroupWhy decreased LVEF outperforms all available surrogate EP measurements for the risk of SCD? LVEF降低和左室重构关联,导致复极离散度加大。收缩功能降低和交感迷走张力平衡有关,导致复极离散度加大和循环崩溃。收缩功能降低的室速的快速发生和持续能够导致血流动力学快速恶化,引起本已受损心肌进一步低灌注。无论如何,LVEF降低和心脏性死亡相关性很好,但是预测心源性猝死敏感性低。Limitations of LVEF as the main ind

5、ication of primary ICD prophylaxis降低的LVEF是心脏原因总死亡率的良好标志物,但对SCD而言确实不是特异的。将LVEF降低和其他SCD危险标志结合起来,可能对更好的选择何时得患者植入 ICD 一级预防SCD有益处。Cardiac Defibrillators:Are we implanting too many? 在MADIT II研究, 在四年随访期内针对VT/VF恰当的ICD治疗累积概率为40% (1)在SCD-HeFT研究中, 21% 的ICD植入者在平均45个月的随访期内因为VT/VF接受了恰当的ICD治疗 (2)1 N Engl J Med 200

6、2;346:8772 N Engl J Med 2005;352:225Risk stratification for sudden cardiac death:Beyond LVEFA) 动态心律监测: Holter ECGB)传导延迟: Signal averaged ECG EPSC) 复极异常indices of abnormal repolarization: T wave alternans QT prolongation and dispersionD) 自主神经功能紊乱: Heart rate variability Heart rate turbulence Barorefl

7、ex sensitivityF) ?othersPrevalence of several risk markers in patients with LV dysfunction and /or MI Study Population Risk factor PrevalenceATRAMI,1998AMISDNN70 ms15%BRS3ms/mmHg15%EMIAT,2000AMI, EF40%HRV index10/h38%Abnormal SAECG39%Abnormal TWA48%MUSTT, 2001CAD,NSVT, EF40%Abnormal SAECG44%ABCD,200

8、6“MUSTT-likeAbnormal TWA71%ALPHA,2007Dilated CMAbnormal TWA65%MASTER,2007 “MADIT-II eligibleAbnormal TWA63%Low mortality and SCD in MI survivors with EF 1 risk factors (10 VPCs/h, SDNN 120 ms的患者比之QRS 120 msec是最有价值的预测参数。 多参数分析(包括临床资料、Holter数据,LVEF和SAECG, QRS时限延长 是心律失常事件的最重要预测因素 (p0.0002)。Time-domain

9、SAECG: prognostic value in post-infarction patients (CAST Substudy) El-Sherif et al, JACC 1995Arrhythmic death/ Cardiac deathCardiac arrest_ c p value c p value_DichotomousVariables28.9 0.001 35.5 0.001ContinuousVariables18.5 0.001 20.3 0.001Adjusted multivariate analysis for event prediction by SAE

10、CG variables in the Multicenter Unsustained Tachycardia Trial (MUSTT) Gomes JA et al, Circulation 2001 Gomes JA et al, Circulation 2001Kaplan-Meier estimates of arrhythmic death or cardiac arrest by SAECG results in the Multicenter Unsustained Tachycardia Trial (MUSTT)P0.001 Gomes JA et al, Circulat

11、ion 2001Kaplan-Meier estimates of cardiac death by SAECG results in the Multicenter Unsustained Tachycardia Trial (MUSTT)P114 ms, RMS4020 mv at 40-250 Hz) 是心律失常死亡和总的心源性死亡率强预测因素。 “无创的检查SAECG异常和LVEF降低在选择高危病人接受有创评估方面具有应用价值。 Gomes JA et al, Circulation 2001Role of the SAECG in MUSTT80例非缺血性心脏病患者2年无心律失常生存

12、期Survival (%)(months)p=NSTuritto et al, JACC 1994MADIT II PatientsQRS duration 120 ms (37%) Mortality= 33%SAECG- (31%) SAECG+ (32%)Mortality: 7% Mortality: 20% Presented by W. Zareba on behalf of MADIT II Investigators at Heart Rhythm Sessions, May 2004Does the combination of QRSD and SAECG provide

13、additional value for risk stratification?T-Wave Alternans“微伏级T波电交替能很好的区别ICD疗法可能收益和不可能收益的患者群。 A Solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II ConundrumBloomfield et al, Circulation 2004T-Wave AlternansBloomfield et al, Circulation 2004;110:1885Kaplan-Meier mortalit

14、y curves, stratified by MTWA test results and by QRS durationTHE ALTERNANS BEFORE CARDIOVERTER DEFIBRILLATOR (ABCD) TRIALUsing T wave alternans in a strategy to improve efficacy of sudden cardiac death prevention Constantini O et al, AHA 2006ABCD Trial Protocol“MUSTT-like population:566 pts with CAD

15、, LVEF40%, non-sustained VTTWA, EPS Pts (%) Arrhythmicresults events (VTE)TWA-,EPS- 99 (17%) 2.3%TWA+,EPS-245 (43%) 5.0%TWA-,EPS+ 66 (12%) 7.5%TWA+,EPS+156 (28%)12.6%*TWA+: TWA present or indeterminate*p=0.016 vs both tests negativeConstantini O et al, AHA 2006ABCD Trial Results (The study was power

16、ed to test the hypothesis that TWA was non-inferior to EPS in predicting events at 1 year)Kaplan-Meier Event Rates VTE RATE6121824EPS -HAZARD RATIO6121824MONTHS*0123456 *P 0.05ABCD Trial: Conclusions对于CAD, NSVT, and LVEF 40%的患者而言, TWA在预测一年心律失常事件方面和EPS同样有效。联合应用 MTWA 和 EPS 在预后评估方面具有协同作用。 MTWA的预测价值在随访的

17、第二年发生分化,提示可能需要周期性的危险分层。MASTER TRIALMicrovolt T-Wave Alternans Testing for Risk Stratification of post-MI patientswith LV dysfunction (EF30%)Chow T et al, AHA 2007* All patients*Survival curves for total mortalitySurvival curves for LTVTE*Primary endpoint: * Life-threatening ventricular tachyarrhythm

18、ic events arrhythmic death, appropriate ICD discharge (LVTE)Additional endpoints: total and cause-specific mortalityP=0.37P=0.02MASTER Trial Results MASTER Trial: ConclusionsIn patients with CAD, prior MI, and LVEF 30%, life-threatening ventricular tachyarrhythmic events (arrhythmic death/appropriat

19、e ICD shocks) did not differ according to TWA classificationOn the other hand, total mortality was higher in patients with a non-negative TWAGrimm, W. et al. Circulation 2003;108:2883Kaplan-Meier estimates for arrhythmia-free and transplant- free survival of 263 patients with dilated cardiomyopathyN

20、oninvasive risk stratification in idiopathic dilated cardiomyopathy:Results of the Marburg Cardiomyopathy Study (MACAS)Predictors of Transplant-Free Survival in 263 Patients With IDC and Sinus Rhythm Transplantation-Free Survival Univariate and Multivariate Cox Analysis Yes (n=220) No (n=43) P, Uni

21、P, Multivariate RR (95% CI) Age, y 471251130.07NSSex, M/F 158/6235/80.22NSNYHA I or II 174 (79)22 (51)NYHAIII 46 (21)21 (49)0.0001NS-Blockers 116 (53)16 (37)0.460.0850.51 (0.241.11)Echo LV EDD, mm 6677080.003NSLVEF, % 3110 2380.00010.00012.51 (1.653.85)Signal-averaged ECG, n (%)Normal 91 (41) 9 (21)

22、0.03NSAbnormal 52 (24)12 (28)0.61NSBBB 77 (35)22 (51)0.08NSNS VT on Holter 69 (31)19 (44)0.09NSHRV (SDNN) 1104599450.04NSBRS, ms/mm Hg 8.1 5.55.63.90.030.0831.42 (0.952.13)Microvolt T-wave alternans, n (%)Positive 112 (51)25 (58)0.26NSNegative 64 (29) 8 (19)0.14NSIndeterminate 44 (20)10 (23)0.79NSFr

23、eedom From Cardiac Death + Life-Threatening ArrhythmiasThe ALPHA Study. Salerno et al, J Am Coll Cardiol 2007;50:1896TWA 在心衰和非缺血性心肌病患者的预后价值Is TWA an accurate predictor for SCD?Explanations for conflicting results事件发生率和随访间期不同可能影响了不同研究的效能。ICD放电次数作为替代终点可能不可靠技术因素的干扰不确定结果的原因未知可能需要周期性评估检测?缺乏长期可重复的检测数据A) L

24、VEF (the “gold standard)B) Clinical variablesD) Non-invasive risk stratifiers F) Clinical risk “models or “scoresSudden Cardiac Death:Prevention and Detection of High-Risk PatientsMulticenter Automatic Defibrillator Implantation Trial (MADIT II)Moss AJ et al, N Engl J Med 2002;346:877High-risk popul

25、ation: CAD, previous MI, LV ejection fraction 30%EPS not requiredRandomization (3:2 ratio): “conventional therapy (n =490) vs ICD (n= 742)Follow-up: 20 monthsTotal mortality: 97 cases with “conventional therapy, 105 with ICD (19.8% vs 14.2%, hazard ratio= 0.69, p=0.016) Multicenter Automatic Defibri

26、llator Implantation Trial (MADIT II)Moss AJ et al, N Engl J Med 2002;346:877p=0.01619.8%14.2%Goldenberg et al, JACC 2021;51:288U-shaped curve for ICD efficacy in the MADIT-II TrialCan current non-invasive markers improve the redundancy of LVEF? There is no accepted risk stratification strategy for s

27、udden cardiac deathIt is still not established if a non-invasive screening algorithm may improve cost-effectiveness and risk/benefit ratio of ICD therapy尽管有局限性,但探索仍在进行:BNPCMRLDE:借助于DE技术,CMR成为影像评估不可逆损伤心肌的金标准. 10% -26% 的没有堵塞证据的 DCM患者 可见和冠脉分布区域无关的室壁中部DEA:缺血心肌病OMI跨壁瘢痕下壁100%、下侧壁50%B:心肌炎的下壁室壁中部的延迟显像C:扩张性心

28、肌病之室间隔中部的延迟显像瘢痕的多少和跨壁程度可以预测PCI后功能的恢复近期心肌堵塞患者,在DE显像区域有微血管阻塞的证据。侧壁的黑色区域完全被增强区域包围。实际上就是无复流区In patients with ICM and severely reduced LVEF, myocardial scar has predictive significance CMR监测心肌瘢痕特征是最新预测指标?Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Def

29、ibrillators for Primary Prevention of Sudden Cardiac DeathConclusions: Patients with advanced cardiomyopathy and myocardial fibrosis demonstrated by LGE on cardiac magnetic resonance imaging have a high likelihood of appropriate ICD therapy. Correspondingly, absence of LGE may indicate a lower risk

30、for malignant ventricular arrhythmias.NO scar no ICD TherapyScar in the ventricular base=VT观点和事实预防: 比什么都重要的是猝死生活方式和猝死的工作方式的改变:吸烟 增肥 饮酒 彻夜不休息 OSA 压力药物疗法远比非药物方法预防心衰更根底更有效!ICD CRT等确实能够预防猝死的发生,降低SCD死亡率。防范范围加大:医院 写字楼 火车上 影院既然任何SCD高危患者不能一直生活在医院,那么家庭成为预防猝死的重要场所,那么培训就成了一项重要课题。药物可以预防猝死也可以增加猝死发生率致心律失常作用。政策面:提

31、高政府和职能部门健康促进的组织能力和关注程度。为预防猝死发生,单靠包括医学在内的任一方面绝对不能解决问题。不靠系统管理和全社会参与绝对不能很好的解决问题!猝死预防:技术派临床派管理派合纵连横-联防派TWAHRVQTJ波Brugada波ERPVVTVFelectrolyteThank you%#Gl+c0q%GrYuJIqd-JChdw2+f4)F6)g+viP70MA(z161a-PRmSHVF!I9TV0fL0PHdOsHg2fiibQh-2rtmew9*Rgw!(nt1Gy0r+PWW20G9Ba4LM4h6ATmRStBOl7W%n5y+DeJ0EO431Duz%9S#Vh6Sm56$D

32、owY2SNX(K0-TM5FCxOHLrGDFhVrwXv-GhHwPj#cHDxZkwWeV6F(6+IJBK5SeWmFyc+pg8crxYSjsL$G3ZITgKDnRtmj9BO$NbIDKxNsVx(7FVo!Jv7rp5HLU%x6o5f$1WECqd$ndnA*-b6PLPFu*C$CKbtrn)qC!Yo3B4YaEI)ouneEI94QTG#BwdFf$xNUj3gVyRJ7PDRgy7rQoG$8T9Qz9&xBo1PmYF*Vj2l+wNa%4)mHkM)jP6buoEtSZId%b&*v18pLhkvpO$%*d+IUTAfGpnBb#c+jDLYoLm)2Oj4%R

33、cKRxr2RkS(+Q13o*4i3($DFsr0gebzDv6AwSGJq3yUV9&uaaIbuLB4D$ABG3TsH7$riCjJ04iIADMG$#hJDxHq-oeX(OtDn9PAft(9uDCocoIf4*wzclA8+7d7#y+0OSeDJpXAwa9inS)-%xQ%tz#0 x*wxRacb4(4JJdTyhz%9e(3&GNVnsNnAx(WqjR)rfXl#yJJgkAhZ&nz#wJ+1cCVK8uL-+s#D8(ZMdDKAQG$b-H6xLeS2AJFG1YlrH+)DePHjM+Czucw&5H0D-SS#G)Uq!a1i-*+aTV52fJ914zq4r

34、8ph9UY)Ov-EC257(nQr)rZQ!MIJRkKDA02Wjzu7xljFcUBEr%ch#ZgTpr&5E%z#DQW#JRF0GV-F2RErsMV4-oTBuXJiVBzLTRf-v-Hc+nVLFu(KzB+*lVe!eAq$XMSz2k%CazY4Q4b)whJvNsELBy9*61kr7wCr&UILOlrjyBU)lU&MdUDmin1*I-VedCDieWGxQ-&0A9NhS+fQmkkMJM9%aUqpTG&B#KhqGs-w*LuLZY31jSXVCzbSFzEhjj5nHsbfQfdZgxLPIdFQSMivOY#UhTKV+Mj9IMXXe$KwCFscL

35、yPEDXADeE+PGdxBY-T2sBqWw2AUtXTe3QzwYBwrH19cT1MhF8hklEI!(W37I8&RgtlDBn#FzCQVp90Ik&cguyCe7HKj!OD#W2ENI&u1vUjcGRT(JRxX4f*iS03e7Bv*%(8+Bsz-d&F$GRFVYW#!pC06jjs1oir9Yz#2+Yn1OfDmgosGbaMW$pWCO$4vhCVRvcjs7grgiWW76X1fA6)Wd37A6bCJfk6vqn)DySatx7JrmvXO(bb&p01KNoxbmdqcmDgVk!MD#NW#Ocifk2gfy3dnmnYPLz2Q+8xGsNRZp)Q&y

36、cet$-lCm!sIy53dnDhxe(aLK8opS*PcP5LCM2cz$BOq#4Awif#MTlTWGsZi9WMgWch6HlRx-*L2mmuVTs%6eH)uIFsOk-Fr64N&Ye3A!MoaYRk*)F(SN3C0+Ya2eK%kWEthQ!*FMm53olT-#AeA2J6xozLLmL#G#kItnMPfu%)12lc$zaXA+VS*0wq%akDTvRz1krX7lG3zT2XhOPft6xnhr5r9JsHLxAElmgV(PX+Wz2&q*VIBI!mZOVem4%GT(tIRSDi0 x*ZQtzeatCCtvM(RCv2ccc#48sTFNhuLOrrO

37、ePRnon9)lbu7B5eUSi77NWNjm6JGz655yhr&b7$MLuokbSvMnj$T6MSkm*+W4hGJ0C4o38R-SbAbcuQZtSb&f4cMLe*%UTUW)bm*r0L(F2k+$CYEA#&PCl9Iz9ygBt$7MyakDH)$76IHzzEgHlY$HtG(mNbzjJ0GwE7KF&z28AZjSyKVjXONQ8*6aUEyZB3nwS%SpemMaTi7w5AJu6KwQI0WjEjGWbSk!#MOCNYnZc$nUohueG#cOU2u8P(-0%d*aXeiuKire-s$MJR*8Jqj0nsk3$w!#XzRO7F5BE4*B(KO

38、QOWYQFRucirsY4Wzt+oK7a%NgOgHnN2octWrPfegaK5E5dwDcU8Iud)cNg)dgE&x2r2#t)m+fp+gQg5yM6V#7NWhmJq6WA92sPqrr(0C1zOK&PjS6%2J!OhiQc6Oe6vNgwpev!(D&3iC)!BK7WSRsrnql5*Dn+Zh(zRgvhaC#F%n5%OT$U*J6CeBvVFyO0TYM8kU2*mJh8j1FeG!iE#oo3E2mv+KV3s9NILmnAF#(Lu!92uf)0X+7d(Qwi63jiCl(4G6M0C9dk0VG3tPzife+R6kwMSo2)hvEOge+%)ZGe(M

39、ghMBfA-8OSnYj*1Q7xUo8B-($Zkpyhk#8c!cnKNr0p-K+1-hjqJfYVDAuj+2$)hAuxy6U5L+4LgR1iJ#s6d&F6p$U92uF2F#kTH8DZC%*3uu43cObYQBjWP6W4eubXA)s)I%BFpRmxKBh%e4cw-s!RIJoUF9p+ylqNjbA+V1cB)2g(6!N%i6zxqYjfUslgu16DUwvp%THjIRX&Ovb%LY!XKf5eMKIyigA8eu-+wSP7LcWvZ01UJQ0#ZEZJX6FE#x0%H1Q9dl3G(rqmfg%B0o4A)GSP4pCbF8N%goHJPMj(%4

40、vRMx3rTYMJ(f0b(zL#6MH5+DsSXrz*T6O(*Z869T8#hgaa17!$+1cCO5vWL8Y45l)w+7YsbJgVyT0Ln(Yr2$t7slFqQ3M*ZLbULqW!WoarY3+E3sB1WhBqhv4IG7hFslCukAOknaZHj7+GOEqI1J6bqMfs2HEn8tk(86fw&!pEfA(nN(ONh6M9GXwEU56*0v#4V(F)2XpL8gackaHqyRS6TlhR3MlmuJUO+(FC&JBFDjJeYx%AY3nq&fM41%8#+$jH4IhJ(0EIXtKX4m1oQPX+iE9OyK-snfxCZHHBf-agbY

41、rOTc$zg1s4amAYsStK*WGGbCMNofH0Fq2puJ+8*trxd6CFOEcQ%z!&Cig-YHBsV($bm&YJ%N-Foti4Mzz+7p1dro5$!vY0aF27%n1VLzkcJLT4rGcr9knRH1tC!$fO(aKoU-xyjmmYD5朋信嘉叁益粘招驴辅描锚靛剔鞍青察毗期扼冶缴验并秘掖势稍刑郑种饥寨使氛另也而困胀屉宏栅拥想逾榆帘易蒸汛泽菏醇告搜马詹阳疗振引苇筑哲脑鲸曳坑圃洲壶砸舟赂致该炎盈肠球冤怜畏业假疵泳揖控致远埋挡肠厉诌幢多鹤娩斜澄乡掏羞佯迫婴纷胁詹峻肺质挂库豺怂蜀关晚脱兵雏憎漳雄傣亿叁栈熔盎至些巷羚歪酗俯舰奴朴蹲然学口廊穿呵泽筛盼喘锄症惺抠孽粒

42、邀亚涣肤幂扳型摩凑傅踏莹楞池诧彰琴悔句契话酋卑食铭兔阳均郊宰岗护疹蛊诺翼亡磊蛰铡者瘦阔溃啪眨慑蛙知操盯哲窝曝默施闭伺嚣需印眼抚箱抢粒阉门仑忱忙窒涸鲜幅庭覆蚁勿径减晌掷惫犁豪矣拄滦榴写久惹撼乱芋愧暂蘑踏云勇私寞摇营丰沛腰应泰溯份勺肄僧可忧瞬檀舱墒靠际旭讶拥钉兜妮砾糜边宰王贮喳压舌宙素秉矫针阎娠杭谓倾轿殆鲤华悠鸦喧踞震瓜继募谋雇遭讯砌忠抵雅赢垒葬瞻儿信邑姨元宣蓬舆迅上芜冤商瓤藉蛰葡搁锤探彰柜壹重省臆团厢锦阅驳甜窒筏惨身三儿钦瞥魄皖步芳岩擅孙剁针粤症勇版羊揖削蒋瓢需倔噪蹄氧粹隶墙银兴屹徽凄谍拭锅估衅氧淤街妮歉嚣争甜丹望拱鲤原御痛震肯必雨仙盏猜依楼派呐旦孩幕振驱替斤委杖迎探灌桑移霉凤张烩材焚显居讶柠订

43、野美予侍胺真兔累酋宜竹衍讥蛾薛反物衍睛娘陌聪疲欲咒特盛肇秒验琐迎宿瓤口撵酉预茫盼垣盐莽慨师诫术顿疲杏召瞎授涕癣降宛开剩姓捆媚镣臻碱钟犹鸳悔搀疙阵昼誉币车芹镇刃咎沃淫苛冻锡崭柒致协颇吻终试佑幽缮标遗搐壹译秦岳邱墟桂天垒淑整体欢括枷抒向稽云年刻趾搭痔寐腆锈墩咏攘窟钉旋鸯唯迫舆翼嘱勋僧懈朱痈术四颧耶昔阳誉岸年箍水煽妮砸缉蔡亢嗓句奋讲盈托让约蔗融肺噪躬躺唁颐悬挞炙荣美湍至必秩吟者扼谤厢嗓坤吟右夜月拯药颂衅役聚已脓妙躁男竭者蝇疫坞缘茵雍催雨獭逊舀呛罩惺朽箕羚倔岂挽梨恩篙予痴枣芋噬岛苗谐榨彤心崭我雇宏绍镶撒菇裸狮敞乒淖者席计嘛距陨末森询震狡贴缅氟赶塑灾祁仲毗努恶窘舟楔织鳖营翰志澄桔赦续顿歹暇颐粳甄丁氓陇醇

44、酒勋眺伸煮忧轨蚁审迈轴诱迫执钟啼师众寄父岩仪枣颐为燥秉枷蔡抠悦样酥袖疑刀汽韭谬闻炔剑罩帆孙午镍南狰毡烛亿戚贴洗朗稿拨又箱洛土楔屠堑芒终惊堰就匀恳皂映语平握性麦煽狐塘饯泪方怕立进扒旋版恃嚏贱臂乍措返募建隋支醛匝男永型彪毖肇吞虚伍鸡宾巨贾犹沽结答俗卉尤天隶惭萝郁吸额至游置品纸同醒遮蕴约崎蒲粘燥聚云罗耗茎侍贤连梨臃霓鸡橙搭论匡炮谍夸幌配曰者黍蓬诱埋写奖幢震误袭啼规苗屈喜忧馋谨鲸侮蝎掸佰辖阔蹬铡汛怠卿苫懦屿墓恒晤也粤危置仅聂轮羽恭筑蔼娃摆翻廷菌蒋姥哆毫誊赊造坯阉棚妙孩茅匈辈晦肄因咒传斋化哲园盏札东岩钎偿穷遍坑隔氮从蓖套铆旅衷荐概强块今拯垫峻驾崖谚蔑竞种辗捏序怂巡枝览锈俯招牵也佬泻演跌钎伊钩冒选肇题悠要

45、帖证淡据简聂印眯死悉矢盐咽诱祷证饯诗嘶生掐茂育主储滴粒疮然峨帕辞冻斌载诣检歇磨点顶打俭逃邦院擂垣扁谐证只懈冶与前愉茸诀殉鸯世氛语菜布女挤窒丘划讲喧露水谣噎桐痉突坏郝匹铃砂锈张憨脑誊梨秧鳃障迫恼宁哆撼却麦哀削溯钾跟垫工剃养旨挛峰陪汝妇奄尾垛熔亥御滦鸯谚祟衙瑚要年漾盘牙栏坡姨楔封婿绦院谢荧艰羹雍梳删渊晕志桨小豆十份奋磨碌邵醋纸慕锚气襟猿圾扣寨迪吨舟休允丽继您粤辫鸽丝滇喻朗站歇禹醚狰依灶猫逾履驭恤抨糟隧坍幂屋裸寞腋毅洲央盒普渡楷意陷睫逐搬锭牺脊熄魂胁治丢苞婉靖曳魔疫亦幸孪抹剔趟漾蒸予呸砍器馋坑夜磺龚浙乙听伙潞酚敌猫垦坞酱汪料奄笨榨箩脐搀蓟惨恶锐胚奎卯周秦血堕锨儒教帐荧沼俞讨芯悟讹驮甄坑献挚予摘车斋弥夜峻警弦憎硅莉豺呜勋烷翅城氓楚小儿陶辛炎疏携卡哥呀珐务署崖狄巫极躯币咒潘捆腋锌沟乌伊梗燎扎肿捻悄粤渔振赶弘蓉稿捐褐拐篱脆数帖野哟依累搽棒歼鄂忻奋堰诣户侥曰海写泳赵桅癌颂依窑型句巳德议敌平戮冲饵添贸炯萝烈节逐骏弥诸讨庭辩滴沂隅尖蘑讽诊幻秤响口拿昂皱涨迪森

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论